Leo Cancer Care Receives FDA 510(k) Clearance for Marie® - A Revolutionary Upright Radiotherapy Platform

Leo Cancer Care earns 510(k) clearance for revolutionary upright radiotherapy platform - Wisconsin Technology Council

Leo Cancer Care, a leader in upright radiotherapy solutions, has received 510(k) clearance from the U.S. Food and Drug Administration for “Marie,” its flagship product. Marie represents a paradigm shift in the delivery of particle therapy, combining an upright patient positioning system and a CT scanner that reimagines the treatment experience for both patients and

Leo Cancer Care Receives FDA 510(k) Clearance for Marie® - A Revolutionary Upright Radiotherapy Platform

MIDDLETON, Wis., July 29, 2025 /PRNewswire/ -- Leo Cancer Care, a leader in upright radiotherapy solutions, today announces that its flagship product, Marie®, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).